This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA719832; GEO: GSE171516 |
| Type | Umbrella project |
| Publications | Lynch KN et al., "Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 Interactions.", Cancers (Basel), 2021 May 3;13(9) |
| Submission | Registration date: 5-Apr-2021
Medical Oncology, Dana-Farber Cancer Institute |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 24 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 24 |
| GEO DataSets | 4 |
Enhanced efficacy of aurora kinase inhibitors in G2/M checkpoint deficient TP53 mutant uterine carcinomas is linked to the summation of LKB1-AKT-p53 interactions encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Other | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA719835 | Homo sapiens | Enhanced efficacy of aurora kinase inhibitors in G2/M checkpoint deficient TP53 mutant uterine carcinomas is linked to the summation of LKB1-AKT-p53 interactions [exome-seq] (Medical Oncology, Dana-Farber...) | | PRJNA719836 | Homo sapiens | Enhanced efficacy of aurora kinase inhibitors in G2/M checkpoint deficient TP53 mutant uterine carcinomas is linked to the summation of LKB1-AKT-p53 interactions [WGS] (Medical Oncology, Dana-Farber...) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA719834 | Homo sapiens | Enhanced efficacy of aurora kinase inhibitors in G2/M checkpoint deficient TP53 mutant uterine carcinomas is linked to the summation of LKB1-AKT-p53 interactions [RNA-seq] (Medical Oncology, Dana-Farber...) |
|